siRNA Nanoparticle Delivery Strategies and Clinical Trial Advances in Tumor Therapy
Open accessThe DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Abstract
siRNA, as a precise, specific, and highly effective gene-silencing therapy, has been extensively studied. Before reaching tumor cell targets, siRNA formulations must overcome multiple extracellular barriers, including clearance from the bloodstream, membrane impermeability, capture by the mononuclear phagocyte system (MPS), rapid renal excretion, endosomal escape, and precise recognition of target cells. These challenges limit siRNA’s clinical application. Consequently, various modifications have been applied to siRNA to enhance transfection efficiency, while researchers continue to pursue improved siRNA-targeting delivery systems. Nanotechnology offers a rational technical approach to address siRNA delivery. Nanoparticles can increase transfection efficiency while exhibiting lower cytotoxicity and reduced off-target effects. Various matrices have been employed to construct nanoparticles for targeted therapeutic delivery. This review briefly discusses siRNA nanoparticle delivery strategies, illustrates examples of various siRNA nanodelivery systems, such as lipid nanoparticles, polymeric siRNA nanoparticles, inorganic nanoparticles, hybrid nanoparticles, and conjugate-siRNA delivery systems, and introduces clinical trials of siRNA-loaded nanoparticles for cancer treatment, which can provide valuable references for further research and clinical application of siRNA nanoparticle delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Together with advances in nanoparticle-mediated siRNA delivery, these findings suggest that biologically inspired delivery systems may further enhance the therapeutic potential of nucleic acid-based radiosensitization strategies by improving intracellular delivery, protecting RNA cargo from degradation, and reducing off-target effects [109,110,111].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Molecular Mechanisms of RNA Interference
Wilson, R. C., & Doudna, J. A. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130404 · Cited by 1,076
Chitosan-based nanomaterials: A state-of-the-art review
Shukla, S. K., Mishra, A. K., Arotiba, O. A., & Mamba, B. B. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.04.043 · Cited by 929
RNA interference in the clinic: challenges and future directions
Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2966 · Cited by 820
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, P., Zhang, Z., Yu, H., Wang, S., et al. (2016) · Advanced Materials · doi:10.1002/adma.201602173 · Cited by 640
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Protein-Based Nanoparticles as Drug Delivery Systems
Hong, S., Choi, D. W., Kim, H. N., Park, C. G., Lee, W., & Park, H. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070604 · Cited by 619
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Innate immune mechanisms of mRNA vaccines
Verbeke, R., Hogan, M. J., Loré, K., & Pardi, N. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.014 · Cited by 501
Sahu, T., Ratre, Y. K., Chauhan, S., Bhaskar, L. V. K. S., Nair, M. P., & Verma, H. K. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102487 · Cited by 487
Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., & Kataoka, K. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044941d · Cited by 476
Kianfar, E. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00896-3 · Cited by 471
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
Tatiparti, K., Sau, S., Kashaw, S., & Iyer, A. (2017) · Nanomaterials · doi:10.3390/nano7040077 · Cited by 429
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Zuckerman, J. E., Gritli, I., Tolcher, A., Heidel, J. D., Lim, D., Morgan, R., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 427
Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov, K., & Saltzman, W. M. (2012) · PubMed Central · Cited by 419
Structures, properties and application of alginic acid: A review
Guo, X., Wang, Y., Qin, Y., Shen, P., & Peng, Q. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.180 · Cited by 409
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz6108 · Cited by 363
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.008 · Cited by 362
Kumthekar, P., Ko, C. H., Paunesku, T., Dixit, K., Sonabend, A. M., Bloch, O., Tate, M., Schwartz, M., Zuckerman, L., Lezon, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3945 · Cited by 345
Aleku, M., Schulz, P., Keil, O., Santel, A., Schaeper, U., Dieckhoff, B., Janke, O., Endruschat, J., Durieux, B., Röder, N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2428 · Cited by 293
siRNA therapeutics: a clinical reality
Saw, P. E., & Song, E.-W. (2020) · Science China Life Sciences · doi:10.1007/s11427-018-9438-y · Cited by 291
Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform
Toledano Furman, N. E., Lupu-Haber, Y., Bronshtein, T., Kaneti, L., Letko, N., Weinstein, E., Baruch, L., & Machluf, M. (2013) · Nano Letters · doi:10.1021/nl401376w · Cited by 273
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
Sajid, M. I., Moazzam, M., Kato, S., Yeseom Cho, K., & Tiwari, R. K. (2020) · Pharmaceuticals · doi:10.3390/ph13100294 · Cited by 252
Nanocarriers and Their Loading Strategies
Wang, N., Cheng, X., Li, N., Wang, H., & Chen, H. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801002 · Cited by 245
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Moazzam, M., Zhang, M., Hussain, A., Yu, X., Huang, J., & Huang, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.005 · Cited by 230
Stem cell-based therapies for cancer treatment: separating hope from hype
Stuckey, D. W., & Shah, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3798 · Cited by 220
Mesenchymal stem cells: A promising targeted-delivery vehicle in cancer gene therapy
Hu, Y.-L., Fu, Y.-H., Tabata, Y., & Gao, J.-Q. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.015 · Cited by 181
Role of vascular normalization in benefit from metronomic chemotherapy
Mpekris, F., Baish, J. W., Stylianopoulos, T., & Jain, R. K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700340114 · Cited by 178
Zhang, J., Chen, B., Gan, C., Sun, H., Zhang, J., & Feng, L. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436038 · Cited by 174
Ahmad, A., Mubarak, N. M., Jannat, F. T., Ashfaq, T., Santulli, C., Rizwan, M., Najda, A., Bin-Jumah, M., Abdel-Daim, M. M., Hussain, S., et al. (2021) · Processes · doi:10.3390/pr9010137 · Cited by 167
Han, J., Wang, Q., Zhang, Z., Gong, T., & Sun, X. (2014) · Small · doi:10.1002/smll.201301992 · Cited by 164
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
Hattab, D., Gazzali, A. M., & Bakhtiar, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071009 · Cited by 163
A Virus‐Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy
Gao, X., Li, S., Ding, F., Liu, X., Wu, Y., Li, J., Feng, J., Zhu, X., & Zhang, C. (2021) · Advanced Materials · doi:10.1002/adma.202006116 · Cited by 160
Lipid-Based Nanoparticles in The Systemic Delivery of siRNA
Lin, Q., Chen, J., Zhang, Z., & Zheng, G. (2014) · Nanomedicine · doi:10.2217/nnm.13.192 · Cited by 133
Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes
Bao, Y., Jin, Y., Chivukula, P., Zhang, J., Liu, Y., Liu, J., Clamme, J., Mahato, R. I., Ng, D., Ying, W., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0874-6 · Cited by 127
El Dika, I., Lim, H. Y., Yong, W. P., Lin, C.-C., Yoon, J.-H., Modiano, M., Freilich, B., Choi, H. J., Chao, T.-Y., Kelley, R. K., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0838 · Cited by 127
Lipid–Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery
Jain, S., Kumar, M., Kumar, P., Verma, J., Rosenholm, J. M., Bansal, K. K., & Vaidya, A. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14090437 · Cited by 124
Polymeric nanoparticles for siRNA delivery: Production and applications
Cavallaro, G., Sardo, C., Craparo, E. F., Porsio, B., & Giammona, G. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.008 · Cited by 123
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800249n · Cited by 121
Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer‐by‐Layer Nanoparticles
Choi, K. Y., Correa, S., Min, J., Li, J., Roy, S., Laccetti, K. H., Dreaden, E., Kong, S., Heo, R., Roh, Y. H., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900018 · Cited by 120
Progress and perspective of inorganic nanoparticle-based siRNA delivery systems
Jiang, Y., Huo, S., Hardie, J., Liang, X.-J., & Rotello, V. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1134486 · Cited by 120
Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA
Li, C., Zhou, J., Wu, Y., Dong, Y., Du, L., Yang, T., Wang, Y., Guo, S., Zhang, M., Hussain, A., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04468 · Cited by 107
Mu, X., Zhang, M., Wei, A., Yin, F., Wang, Y., Hu, K., & Jiang, J. (2021) · Nanoscale · doi:10.1039/d0nr08024a · Cited by 105
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
Tai, W. (2019) · Molecules · doi:10.3390/molecules24122211 · Cited by 102
PEI fluorination reduces toxicity and promotes liver-targeted siRNA delivery
Xue, L., Yan, Y., Kós, P., Chen, X., & Siegwart, D. J. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00790-9 · Cited by 96
miRNA Delivery by Nanosystems: State of the Art and Perspectives
Moraes, F. C., Pichon, C., Letourneur, D., & Chaubet, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111901 · Cited by 95
Hu, Y.-L., Huang, B., Zhang, T.-Y., Miao, P.-H., Tang, G.-P., Tabata, Y., & Gao, J.-Q. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300254s · Cited by 87
Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy
Sanchez-Salcedo, S., Vallet-Regí, M., Shahin, S. A., Glackin, C. A., & Zink, J. I. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2017.12.116 · Cited by 77
Choi, S. W., Lee, S. H., Mok, H., & Park, T. G. (2010) · Biotechnology Progress · doi:10.1002/btpr.310 · Cited by 74
Schultheis, B. S., Strumberg, D., Kuhlmann, J. B., Wolf, M., Link, K., Seufferlein, T. T. W., Kaufmann, J., Feist, M., Gebhardt, F., Khan, M., et al. (2020) · Cancers · doi:10.3390/cancers12113130 · Cited by 72
Kalluri, V. S., Smaglo, B. G., Mahadevan, K. K., Kirtley, M. L., McAndrews, K. M., Mendt, M., Yang, S., Maldonado, A. S., Sugimoto, H., Salvatierra, M. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63718-2 · Cited by 70
Semrau, D., Xu, T., Shevchenko, N. A., Paskov, M., Alvarado, A., Killey, R. I., & Bayvel, P. (2016) · Optics Letters · doi:10.1364/ol.42.000121 · Cited by 70
Poly (propylene imine) dendrimer: A potential nanomaterial for electrochemical application
Idris, A. O., Mamba, B. B., & Feleni, U. (2020) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2020.122641 · Cited by 69
Shaabani, E., Sharifiaghdam, M., De Keersmaecker, H., De Rycke, R., De Smedt, S., Faridi-Majidi, R., Braeckmans, K., & Fraire, J. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020831 · Cited by 68
Lio, D. C. S., Liu, C., Oo, M. M. S., Wiraja, C., Teo, M. H. Y., Zheng, M., Chew, S. W. T., Wang, X., & Xu, C. (2019) · Nanoscale · doi:10.1039/c9nr06303j · Cited by 62
Calcium phosphate nanoparticles-based systems for siRNA delivery
Xu, X., Li, Z., Zhao, X., Keen, L. J., & Kong, X. (2016) · Regenerative Biomaterials · doi:10.1093/rb/rbw010 · Cited by 61
Systemic Delivery of siRNA by Chimeric Capsid Protein: Tumor Targeting and RNAi Activity in Vivo
Choi, K.-M., Kim, K., Kwon, I. C., Kim, I.-S., & Ahn, H. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300211a · Cited by 60
Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles
Mehta, A., Dalle Vedove, E., Isert, L., & Merkel, O. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2665-9 · Cited by 53
Varghese, A. M., Ang, C., DiMaio, C. J., Javle, M. M., Gutierrez, M. E., Yarom, N., Stemmer, S. M., Golan, T., Geva, R., Semenisty, V., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.tps4672 · Cited by 52
Zhang, Y., Liu, H., Zhen, W., Jiang, T., & Cui, J. (2025) · Carbohydrate Research · doi:10.1016/j.carres.2025.109426 · Cited by 50
Ionizable polymeric micelles (IPMs) for efficient siRNA delivery
Zhou, Z., Yu, F., Jiang, M., Yao, Z., Wang, J., Pan, F., Feng, R., Zhao, C., Ma, Y., Zhou, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55721-w · Cited by 49
Chan, C., Du, S., Dong, Y., & Cheng, X. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666201126162945 · Cited by 46
Jagdale, S., Narwade, M., Sheikh, A., Md, S., Salve, R., Gajbhiye, V., Kesharwani, P., & Gajbhiye, K. R. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122894 · Cited by 43
Different-Length Hydrazone Activated Polymers for Plasmid DNA Condensation and Cellular Transfection
Priegue, J. M., Lostalé‐Seijo, I., Crisan, D. N., Granja, J. R., Fernández‐Trillo, F., & Montenegro, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00252 · Cited by 42
A photoresponsive antibody–siRNA conjugate for activatable immunogene therapy of cancer
Wang, X., Xiao, X., Feng, Y., Li, J., & Zhang, Y. (2022) · Chemical Science · doi:10.1039/d2sc01672a · Cited by 41
Mayer, J. B., Patil, S. M., Shin, S.-H., Yoo, J., & Won, Y.-Y. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00419 · Cited by 38
Antibody–siRNA conjugates (ARC): Emerging siRNA drug formulation
Cao, W., Li, R., Pei, X., Chai, M., Sun, L., Huang, Y., Wang, J., Barth, S., Yu, F., & He, H. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100128 · Cited by 37
Cytomembrane‐Mediated Transport of Metal Ions with Biological Specificity
Zhang, M., Ye, J., Li, C., Xia, Y., Wang, Z., Feng, J. X., & Zhang, X. (2019) · Advanced Science · doi:10.1002/advs.201900835 · Cited by 35
Soni, S., Kori, S. K., Nema, P., Iyer, A. K., Soni, V., & Kashaw, S. K. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673278936240107121907 · Cited by 34
Kara, G., Malekghasemi, S., Özpolat, B., & Denkbaş, E. B. (2021) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2021.127622 · Cited by 33
Overcoming Barriers: Clinical Translation of siRNA Nanomedicines
Tieu, T., Wei, Y., Cifuentes‐Rius, A., & Voelcker, N. H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100108 · Cited by 33
Approaches to Visualising Endocytosis of LDL-Related Lipoproteins
Siddiqui, H., Yevstigneyev, N. S., Madani, G., & McCormick, S. P. A. (2022) · Biomolecules · doi:10.3390/biom12020158 · Cited by 30
Protein-Based Nanoparticle Vaccines for SARS-CoV-2
Sung, H.-D., Kim, N., Lee, Y., & Lee, E. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413445 · Cited by 29
Li, T., Wang, G., Tan, Y., & Wang, H.-J. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.6719 · Cited by 29
Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA
Miller, A. J., Chang, A., & Cunningham, P. N. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.09.011 · Cited by 27
Torgal, S., Subramani, G., & Manian, R. (2024) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-024-06350-2 · Cited by 26
siRNA-based delivery systems: Technologies, carriers, applications, and approved products
Ghasemiyeh, P., & Mohammadi‐Samani, S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177441 · Cited by 26
Sun, D., Zhu, L., Yao, D., Chen, L., Fu, L., & Ouyang, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.001 · Cited by 25
Luo, W., Cheng, W., Ni, S., Zhu, X., & Wu, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144862 · Cited by 24
You, S., Luo, Z., Cheng, N., Wu, M., Lai, Y., Wang, F., Zheng, X., Wang, Y., Liu, X., Liu, J., et al. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01237-z · Cited by 24
Cell-Specific siRNA Delivery by Peptides and Antibodies
Lee, S., Siefert, A. L., Beloor, J., Fahmy, T. M., & Kumar, P. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416039-2.00005-7 · Cited by 24
Protein-based Nanoparticle Vaccine Approaches Against Infectious Diseases
Tapia, D., Reyes‐Sandoval, A., & Sanchez-Villamil, J. I. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.02.003 · Cited by 22
Alagesan, B., Varghese, A. M., Ang, C., Gutiérrez, M., Kamar, M., Passhak, M., Geva, R., Yarom, N., Lahav, M., Ligresti, R., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-3189 · Cited by 21
Non-Viral Systems Based on PAMAM-Calix-Dendrimers for Regulatory siRNA Delivery into Cancer Cells
Леонидович, П. П., Shiabiev, I., Pysin, D., Gerasimova, T. P., Ranishenka, B., Stanavaya, A., Abashkin, V., Shcharbin, D., Shi, X., Shen, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312614 · Cited by 21
Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics
Sristi, Almalki, W. H., Karwasra, R., Gupta, G., Singh, S., Sharma, A., Sahebkar, A., & Kesharwani, P. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.01.001 · Cited by 20
Gold Nanoparticle Delivery of Glut1 SiRNA Facilitates Glucose Starvation Therapy in Lung Cancer
Li, J., Yu, J., Fang, Q., Du, Y., & Zhang, X. (2024) · ChemBioChem · doi:10.1002/cbic.202400239 · Cited by 18
Cai, Y., Qiao, M., Xie, X., Zhou, Y., Yu, R., Song, F., Wang, H., Zhang, H., & Sun, X. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159665 · Cited by 17
Structure–Activity Relationship of Ionizable Lipids for siRNA and mRNA Lipid Nanoparticle Design
Lee, S. M., Sun, Y., Chatterjee, S., Xiong, H., Cheng, Q., Wang, X., & Siegwart, D. J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00463 · Cited by 17
Lipid-based Vehicles for siRNA Delivery in Biomedical Field
Li, T., Huang, L., & Yang, M. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666190924164152 · Cited by 17
Bhattacharya, S., Chatterjee, D., & Datta, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107068 · Cited by 15
Efficient delivery of small RNAs to podocytes in vitro by direct exosome transfection
Lange, T., Maron, L., Weber, C., Biedenweg, D., Schlüter, R., & Endlich, N. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03426-7 · Cited by 15
Gupta, C., Yadav, H., Dhanwani, I., & Gulati, S. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03503 · Cited by 15
Dang, M. N., Suri, S., Li, K., Casas, C. G., Stigliano, G., Riley, R., Scully, M. A., Hoover, E. C., Aboeleneen, S. B., Kramarenko, G. C., et al. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300426 · Cited by 14
Kim, H. J., Kim, A., & Miyata, K. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100428 · Cited by 14
Ni, W., Zhang, M., Mo, Y., Du, W., Liu, H., Wang, Z., Cui, Y., Zhang, H., Wang, Z., Liu, L., et al. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01690-y · Cited by 14
Ning, H., Jiang, Y., Li, B., Ren, J., Ran, A., Li, W., & Xiao, B. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125666 · Cited by 14
Chen, P., Wang, Z., Wang, X., Gong, J., Ju, S., Pan, Y., Zhu, D., & Liu, X. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070936 · Cited by 14
Self-citationMostafa, S., Boushehri, M. A. S., Ezzat, A. A., Weiskirchen, R., Lamprecht, A., Mansour, S., & Tammam, S. N. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00715 · Cited by 13
Ganjalinia, A., Akbari, S., & Solouk, A. (2021) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2021.1880935 · Cited by 13
Li, Y., Tian, H., Ding, J., Lin, L., Chen, J., Gao, S., & Chen, X. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500165 · Cited by 12
Spray-drying of PEI-/PPI-based nanoparticles for DNA or siRNA delivery
Noske, S., Karimov, M., Krüger, M., Lilli, B., Ewe, A., & Aigner, A. M. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114297 · Cited by 12
Ferreira, D., Fernandes, A. R., & Baptista, P. V. (2024) · Cancer Nanotechnology · doi:10.1186/s12645-024-00256-4 · Cited by 12
Xu, P.-W., Yu, M., Xiao, Z.-H., Chen, R., & Zhang, X. (2025) · Journal of Biomaterials Applications · doi:10.1177/08853282251366027 · Cited by 12
Minassian, G. B., Ghanem, E., Hage, R. E., & Rahme, K. (2023) · Nanotheranostics · doi:10.7150/ntno.79050 · Cited by 12
Yadav, K., Gnanakani, S. P. E., Sahu, K. K., Sucheta, Dubey, A., Minz, S., Raza, W., & Pradhan, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125049 · Cited by 11
Lian, B., Li, J., Tang, S., Li, J., & Li, J. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01336-w · Cited by 11
Wan, Y., Yang, Y., Lai, Q., Wang, W., Wu, M., & Feng, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122789 · Cited by 11
Development and Characterization of Modified Chitosan Lipopolyplex for an Effective siRNA Delivery
Supe, S., Upadhya, A., Dighe, V. D., & Singh, K. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-023-02728-z · Cited by 11
Ren, Q., Tian, T., Wang, B., Pan, J. P., Huang, Y. D., Li, Z., Wang, Y., Wang, X., & Huang, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141153 · Cited by 10
Wang, Y., Shu, H., Cheng, G., Zhou, X. C., Gao, H., Qi, Z., Ma, X., Zhang, W., & Wang, J. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102856 · Cited by 10
Zhao, L., Lin, X., Ge, N., Kuo, M., Wang, S., Shi, Q., Bao, H., & Yang, Y. (2025) · JACS Au · doi:10.1021/jacsau.5c00474 · Cited by 9
Matsuo-Tani, A., Matsumoto, M., Hiu, T., Kamiya, M., Geng, L., Takayama, R., Ushiroda, Y., Kato, N., Nakamura, H., Yoshida, M., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101298 · Cited by 9
Anticancer Effects of MAPK6 siRNA ‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer
Toruntay, C., Poyraz, F. Ş., Süsgün, S., Yücesan, E., & Mansuroğlu, B. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70309 · Cited by 8
Alarcón, J. F., Artigues, M., Rodriguez-Camenforte, N., Sitia, G., Guerra‐Rebollo, M., Borrós, S., & Fornaguera, C. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123164 · Cited by 8
Mohajeri, S., Dashti, S., Noruzpour, M., Bourang, S., & Yaghoubi, H. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07458-4 · Cited by 7
Oligosaccharide and alkyl chain-modified polyethyleneimines for efficient siRNA delivery
Chen, L., Chen, S., Yi, Z., Wu, X. T., Zhong, S., Mao, L., Wang, Z., Shuai, Q., & Li, X. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.113988 · Cited by 6
Rajoriya, V., Gupta, R., Vengurlekar, S., & Jain, S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125312 · Cited by 6
Yi, M.-F., Chen, L., He, H.-L., Shi, L., Shao, C., & Zhang, B. (2021) · Journal of Central South University · doi:10.1007/s11771-021-4697-7 · Cited by 6
Kwak, M., Hua, T. C., Jin, H., Lee, J. S., & Kim, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178467 · Cited by 6
Das, R., Medeiros, J., Krishna, J., Munugoti, S., Dutta, R., Devarajan, A., Ghosh, A., & Thayumanavan, S. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00205 · Cited by 5
Wakamori, K., Hashikawa, Y., Urata, H., & Wada, S. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118383 · Cited by 5
Maeshima, R., Tagalakis, A. D., Gyftaki-Venieri, D. A., Jones, S. A., Rye, P. D., Tøndervik, A., Åstrand, O. A. H., & Hart, S. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400510 · Cited by 5
Theranostic Iron-Oxide Based Nanoplatforms in Oncology
Savari, M.-N., & Jabali, A. (2023) · Nanomedicine and nanotoxicology · doi:10.1007/978-981-99-6507-6 · Cited by 5
Applications of Lipidic and Polymeric Nanoparticles for siRNA Delivery
Şenel, B., & Büyükköroğlu, G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86920 · Cited by 5
Zhang, M., Xie, N., Wu, D.-Y., Wu, C.-X., Guo, Y., Wang, N.-N., Li, X.-Y., Liang, Y., Xie, X., Wang, T., et al. (2025) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2025.115284 · Cited by 4
Self-citationTargeted melanoma therapy: High-efficiency siRNA delivery with R8-PEI dissolvable microneedles
He, Y., Chen, S., Song, W., Wu, W., Rao, Z., Wang, X., Fang, L., Shi, J., & Wang, J. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125516 · Cited by 4
The Potential of Noncoding RNAs-siRNAs in Cancer Research and Therapy: Challenges and Solutions
Himanshu, Bashir, M., Lone, M. R., & Maqbool, M. (2026) · Experientia supplementum · doi:10.1007/978-3-032-06948-1_5 · Cited by 4
He, Y., Wan, N., Deng, H., Zhang, Y., Liu, Q., Li, L., Liu, H., He, X., & Zhu, Q. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115616 · Cited by 3
Shishira, P. S., Banerjee, T., Ghosh, B., & Biswas, S. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504519 · Cited by 3
Large-Scale Production and Therapeutic Evaluation of Exosomes for Cancer Treatment
Gebologlu, I. K., & Öncel, S. Ş. (2025) · Thoracic research and practice · doi:10.4274/thoracrespract.2025.s011 · Cited by 3
Poletaeva, J., Chelobanov, B. P., Epanchintseva, A. V., Tupitsyna, A. V., Dovydenko, I. S., & Ryabchikova, E. I. (2025) · Nanomaterials · doi:10.3390/nano15181419 · Cited by 3
Loop-Structured PEG-Lipoconjugate Enhances siRNA Delivery Mediated by Liner-PEG Containing Liposomes
Gladkikh, D. V., Shmendel, E. V., Makarova, D. M., Maslov, M. A., Аркадьевна, З. М., & Chernolovskaya, E. L. (2025) · Molecules · doi:10.3390/molecules30204127 · Cited by 3
Tazawa, H., Ishida, Y., Suzuki, T., Shimizu, Y., & Tashiro, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-32407-x · Cited by 3
Buntum, T., Jaruseranee, N., Khongkow, M., Ruktanonchai, U., Uludağ, H., & Suwantong, O. (2025) · Polymer · doi:10.1016/j.polymer.2025.129019 · Cited by 2
Construction of a visualized liver-targeting siRNA delivery system
Sun, D., Jin, G., Jin, Z., Jin, Y. J., Sun, J., Han, L., & Quan, J.-S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104566 · Cited by 2
Complexation of siRNA with Galactose-Functionalized Dendrimers: PAMAM vs PETIM
Maity, T., Kumar, Y., & Maiti, P. K. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c03613 · Cited by 1
Jbara-Agbaria, D., Agbaria, M., & Golomb, G. (2025) · Nano Trends · doi:10.1016/j.nwnano.2025.100162 · Cited by 1
Iemitsu, K., Yoshii, K., Hirayama, Y., Liu, Z., Hifumi, S., Kondo, S., Ishida, K., Nagatake, T., & Kunisawa, J. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100956 · Cited by 1
Targeted lipid‐siRNA complexes for Spp1 silencing in Alzheimer's Disease
Abdulrahman, A. M., Francini, N., Ligocki, A. P., Sorets, A. G., Kjar, A., Schrag, M., Duvall, C. L., & Lippmann, E. S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70861_109009 · Cited by 1
Savari, M.-N., & Jabali, A. (2023) · Nanomedicine and nanotoxicology · doi:10.1007/978-981-99-6507-6_7 · Cited by 1
PEGylated Chitosan–Albumin Nanocomposite for Efficient siRNA Delivery Against Lung Cancer
Yan, L., Suo, L., Xu, J., & Cao, H. (2025) · Nano LIFE · doi:10.1142/s1793984425500060 · Cited by 1
Perera, R. J., Al‐Ahdal, M. N., Jallo, G. I., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf193.313
Hattori, Y., Kurihara, A., & Shinkawa, M. (2025) · Biomedical Reports · doi:10.3892/br.2025.2085
Cited by
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“…siRNA delivery, these findings suggest that biologically inspired delivery systems may further enhance the therapeutic potential of nucleic acid-based radiosensitization strategies by improving intracellular delivery, protecting RNA cargo from degradation, and reducing off-target effects [109–111].”
Cyclodextrin platforms for siRNA delivery: turning design into new therapies
Sonje, D. P., & Wairkar, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126948
Chien, Y.-T., Huang, J., Zhao, Y., Zhou, Y., Zhang, M., & Mu, Q. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167285
“Hydrophobic chemotherapeutics require stable incorporation to prevent premature release, whereas siRNA is highly hydrophilic, negatively charged, and prone to degradation and endosomal trapping [34].”
Ionizable Cholesterol‐Integrated Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors
Kang, S., Nguyen, D., & Jon, S. (2026) · ChemMedChem · doi:10.1002/cmdc.70464
“Besides, the i‐Chol‐LNP formulation could be further optimized to achieve tissue‐specific tropism, expanding applications of RNAi therapy in nonon‐ cology fields such as genetic disorders and inflammatory diseases [28–30].”
Metadata
- Authors
- Wang, P., Gong, J., Xu, Y., & Xia, X.
- Affiliations
- Hunan University of Traditional Chinese Medicine (CN)
- Corresponding author
- Xia, Xinhua
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-03-26
- Volume
- 27
- Issue
- 7
- Pages
- 3032
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC13073686
- OpenAlex
- W7140659748
- Cited by
- 4
- References
- 150
- Citations by year
- 2026: 4
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Science Foundation of China https://ror.org/01h0zpd94 (81573621)
- Hunan Provincial Natural Science Foundation—Departmental Joint Fund (2025JJ80199)
- Key Research and Development Plan of Hunan Province (2017SK2122)
- Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine (202302)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- siRNA, nanoparticle delivery, lipid nanoparticles, polymeric nanoparticles, inorganic nanoparticles, hybrid nanostructures, endosomal escape, transfection efficiency, siRNA modification, cancer gene therapy, clinical trials
- MeSH terms
- Nanoparticle Drug Delivery System, Animals, Clinical Trials as Topic, Humans, Neoplasms, Genetic Therapy, Drug Delivery Systems, Gene Transfer Techniques, RNA Interference, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.